Endurant Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,696
Closed -$3M 49
2023
Q2
$3M Buy
+31,696
New +$2.68M 2.62% 13
2018
Q2
Sell
-22,542
Closed -$1.41M 68
2018
Q1
$1.41M Sell
22,542
-79,229
-78% -$5.44M 0.53% 47
2017
Q4
$6.24M Buy
101,771
+15,200
+18% +$940K 1.91% 20
2017
Q3
$5.79M Sell
86,571
-14,120
-14% -$998K 1.76% 20
2017
Q2
$7.85M Buy
100,691
+7,400
+8% +$558K 2.22% 20
2017
Q1
$7.61M Buy
93,291
+44,191
+90% +$3.48M 2.45% 13
2016
Q4
$3.53M Buy
49,100
+40,000
+440% +$2.89M 1.46% 28
2016
Q3
$707K Buy
+9,100
New +$735K 0.26% 62
2016
Q2
Sell
-5,200
Closed -$426K 90
2016
Q1
$426K Sell
5,200
-12,300
-70% -$1M 0.14% 73
2015
Q4
$1.56M Buy
17,500
+1,800
+11% +$153K 0.52% 51
2015
Q3
$1.21M Buy
+15,700
New +$1.31M 0.4% 56
2015
Q2
Sell
-46,800
Closed -$4.22M 96
2015
Q1
$4.22M Sell
46,800
-26,000
-36% -$2.24M 1.4% 23
2014
Q4
$5.88M Buy
+72,800
New +$5.75M 2.31% 14

Other funds holding CAH

Endurant Capital Management's CAH Position: Q3 2023 in Review

Endurant Capital Management sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 31,696 shares — an estimated $3M sold.

Endurant Capital Management first reported a position in CAH in Q4 2014 and held it in 13 quarters. The position peaked at $7.85M in Q2 2017. 949 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Endurant Capital Management reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Endurant Capital Management sold 31,696 Cardinal Health shares in Q3 2023, an estimated $3M.
  • Endurant Capital Management first reported a position in Cardinal Health in Q4 2014 and held it in 13 quarters.
  • Endurant Capital Management's Cardinal Health position peaked at $7.85M in Q2 2017.
  • 949 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Endurant Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.